Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
YS Biopharma Granted Patent in the U.S. for Immunotherapy Targeting Chronic Hepatitis B Virus Infection 2023-09-15 20:30
Prenetics Announces Second Quarter 2023 Financial Results 2023-09-15 19:10
MGI Introduces New Chapter in Smart Laboratory Management with Official Opening of αLab in HKSTP 2023-09-15 18:35
The "Jiangsu-Germany Dialogue 2023" Held in Changzhou 2023-09-15 16:38
Green Leadership Award Presented to Chugai Pharma Taiwan at the Asia Responsible Enterprise Awards 2023 2023-09-15 11:37
MGI Partners with National Cancer Centre Singapore to Undergo Comprehensive Genomic Profiling of Asian-Prevalent Cancers 2023-09-15 11:00
MedAlliance Announces Enrollment of over 1,660 Patients in Landmark SELUTION DeNovo Study 2023-09-15 08:00
Cure Genetics and Frametact Reach a $60 Million Collaboration and Licensing Agreement for the Development of Gene Therapy for Familial Neurological Diseases 2023-09-14 23:00
Foundry Mixer Healthcare, Indonesian Minister of Health Budi G. Sadikin: "Together We Leapfrog Indonesia's Healthcare Transformation" 2023-09-14 17:47
Dizal Announces China CDE Acceptance of New Drug Application for Golidocitinib for Relapsed or Refractory PTCL 2023-09-14 17:07
Asieris' New Drug APL-1401 Completes First Administration in Patient with Moderately to Severely Active UC 2023-09-14 16:54
Nona Biosciences Expands Antibody Discovery Collaboration with BeiGene 2023-09-14 16:00
MGI and Bio-Medical Science Sign MOU to Deliver Cutting-Edge Sequencing Platforms and Reagents to South Korea 2023-09-14 09:00
AWAK TECHNOLOGIES RAISES US$20+ MILLION, READYING ITS WEARABLE DIALYSIS DEVICE FOR US-BASED PIVOTAL TRIAL 2023-09-13 21:27
Exelixis and Insilico Medicine Enter into Exclusive Global License Agreement for ISM3091, a Potentially Best-in-Class USP1 Inhibitor 2023-09-13 20:29
Asieris Announces Positive Interim Analysis Results in Phase II Clinical Trial of Oral APL-1202 in Combination with Tislelizumab, a PD-1 inhibitor, as Neoadjuvant Therapy for Muscle Invasive Bladder Cancer 2023-09-13 19:09
Singleron launches AccuraCode® TCR library construction kit, enhancing efficiency and cost-effectiveness of high-throughput T-cell receptor profiling 2023-09-13 17:51
J INTS BIO, WCLC 2023 - Presentation of Phase 1/2 study of 'JIN-A02', a Novel Oral 4th Generation EGFR TKI 2023-09-13 15:58
Zuberitamab (Anruixi®), the first domestically developed anti-CD20 antibody as a Class I innovative drug from BioRay Pharmaceutical, has been approved for marketing in China 2023-09-13 14:24
Caliway Announces CBL-514 Phase 2 Study Topline Results for Dercum's Disease, Showing 64.5% of Lipomas with Complete Clearance or Dimensions Reduction of Over 50% and Reduced Pain by 4.7 2023-09-13 13:42
1 81 82 83 84 85 452